Results 1 to 10 of about 2,675 (163)

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer. [PDF]

open access: yesCell Death Discov
Sabbioni S   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy